Table 4.
Patients’ biological profile at day 7 in the three treatment groups
| Parameters | DHAPQ (N = 176) | AL (N = 178) | ASAQ (N = 180) | p value |
|---|---|---|---|---|
|
Hb mean (g/dl) |
10.74 |
10.75 |
10.96 |
0.19 |
|
Anemia (Hb < 11 g/dl) (%) |
63.64 |
70.79 |
69.44 |
0.31 |
|
ALAT (UI/L, mean ± SD) |
16.42 |
17.34 |
18.19 |
0.58 |
|
ASAT (UI/L, mean ± SD) |
25.6 |
23.9 |
25.8 |
0.09 |
|
Patients with ALAT < 40 UI/L (%) |
90.34 |
93.82 |
91.67 |
0.47 |
|
Patients with ASAT < 40 UI/L (%) |
90.91 |
95.51 |
98.89 |
0.002 |
|
Mean bilirubin (mg/dl) |
0.56 |
0.58 |
0.64 |
0.02 |
|
Patients with normal level of bilirubin (0.23 – 1 mg/dl) (%) |
96.59 |
96.07 |
93.89 |
0.42 |
|
Mean creatinine (mg/l) |
7.74 |
7.31 |
7.72 |
0.93 |
| Patients with normal level of creatinine (6 – 14 mg/l) (%) | 96.59 | 96.07 | 100 | 0.03 |